Stocks Health care MDT
NYSE · Health careMedtronic plc (MDT)
Medtronic plc brought in $37.5B of revenue over the twelve months to July 31, 2026, up 9.8% from a year earlier. Net income was $5.2B, a net margin of 13.9%. Operating cash flow minus capital spending left $5.4B of free cash flow in fiscal 2026. At July 31, 2026 it held $1.7B in cash against $25.6B of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on September 3, 2026.
What Medtronic plc does
Medtronic designs and manufactures medical devices and therapeutic technologies. Its products include pacemakers, insulin pumps, surgical tools, and spinal implants. These devices are purchased by hospitals, clinics, and healthcare providers to treat cardiovascular, neurological, and metabolic conditions. Its shares trade on NYSE under the ticker MDT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2026 | $36.4B | $4.8B | $3.73 | $5.4B |
| 2025 | $33.5B | $4.7B | $3.61 | $5.2B |
| 2024 | $32.4B | $3.7B | $2.76 | $5.2B |
| 2023 | $31.2B | $3.8B | $2.82 | $4.6B |
| 2022 | $31.7B | $5B | $3.73 | $6B |
| 2021 | $30.1B | $3.6B | $2.66 | $4.9B |
Latest SEC filings
What Medtronic plc has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 25, 2026Form 425 filing 425
- September 25, 2026Form 425 filing 425
- September 24, 2026Form 425 filing 425
- September 23, 2026Form 425 filing 425
- September 22, 2026Form 425 filing 425
- September 21, 2026Form 425 filing 425
- September 21, 2026Form 425 filing 425
- September 21, 2026Form 425 filing 425
- September 18, 2026Form 425 filing 425
- September 17, 2026Form 425 filing 425
Questions about MDT
What does Medtronic plc do?
Medtronic designs and manufactures medical devices and therapeutic technologies. Its products include pacemakers, insulin pumps, surgical tools, and spinal implants. These devices are purchased by hospitals, clinics, and healthcare providers to treat cardiovascular, neurological, and metabolic conditions. Its shares trade on NYSE under the ticker MDT.
Is Medtronic plc profitable?
Yes. Over the twelve months to July 31, 2026 it reported net income of $5.2B on revenue of $37.5B, a net margin of 13.9%.
How much revenue does Medtronic plc make?
Over the twelve months to July 31, 2026 Medtronic plc reported revenue of $37.5B. That is 9.8% more than a year earlier.
When did Medtronic plc last report?
Its most recent periodic report is the quarterly report (10-Q) filed on September 3, 2026. It covers the period to July 31, 2026. Its newest filing of any kind is the form 425 filing from September 25, 2026.
Similar companies
Follow MDT
Get an email when Medtronic plc files with the SEC: results, executive changes, material agreements and annual reports.
Follow MDT: get an email when it filesWhere the numbers come from
Financial figures are the values Medtronic plc tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.